39 results
425
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Business combination disclosure
6:02am
Factors—Risk Factors Related to the Merger” is amended and restated by replacing it with the following:
AMTI and Cyclo may be targets of securities class … ” is amended and restated by replacing it with the following:
AMTI and Cyclo may be targets of securities class action and derivative lawsuits which
8-K
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
18 Dec 23
Other Events
6:01am
Factors—Risk Factors Related to the Merger” is amended and restated by replacing it with the following:
AMTI and Cyclo may be targets of securities class … ” is amended and restated by replacing it with the following:
AMTI and Cyclo may be targets of securities class action and derivative lawsuits which
424B3
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
21 Nov 23
Prospectus supplement
9:15am
of the combined company.
AMTI and Cyclo may be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay … of AMTI.
AMTI and Cyclo may be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay
S-4/A
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
20 Nov 23
Registration of securities issued in business combination transactions (amended)
8:50am
may be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay or prevent the Merger from … be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay or prevent the Merger from being
S-4
CYTH
Cyclo Therapeutics Inc - Ordinary Shares
7 Nov 23
Registration of securities issued in business combination transactions
4:45pm
be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay or prevent the Merger from being completed … may be targets of securities class action and derivative lawsuits which could result in substantial costs and may delay or prevent the Merger from
8-K
EX-10.1
401 rb7hcr497ac
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.4
ycetq5ret98az3m
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.3
t16hzrm 2f7cyt
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.2
dtvjnsmzr3c
2 Mar 22
Departure of Directors or Certain Officers
4:30pm
8-K
EX-10.1
8ez86
25 Jun 21
Departure of Directors or Certain Officers
4:03pm
424B4
ogpmi0eqj 5yd5tp9y7
11 Dec 20
Prospectus supplement with pricing info
1:38pm
424B4
zj3x6xj03d 2ahstfkgp
11 Dec 20
Prospectus supplement with pricing info
12:00am